Vitalstoffe – Das Magazin für Mikronährstoffe und deren Wirkungen

V italstoffe
48
Momordica charantia kann als Gemüse
wie auch als Zubereitung zur Nahrungsergänzung,
metabolische Vorgänge innerhalb
des Kohlenhydratstoffwechsels
ernährungsphysiologisch unterstützen.
Die Bittermelone eine interessante Option
zur Prävention von diabetogenen
Risikopatienten zu sein, die z.B. an
Übergewicht leiden und die Medikamente
anwenden, die die Glucosetoleranz
beeinflussen. Die Forschungsarbeiten,
Literatur:
neue effektivere Bittermelonensorten
zu testen bzw. zu züchten, werden von
der Beratungsgruppe für entwicklungsorientierte
Agrarforschung (BEAF) der
Deutschen Gesellschaft für Technische
Zusammenarbeit (GTZ) im Auftrag des
Bundesministeriums für wirtschaftliche
Zusammenarbeit und Entwicklung gefördert.
Es ist zu hoffen, dass die Studienergebnisse
eine neue Basis für neue
Therapieoptionen darstellt.
Autor:
Jens Bielenberg
Apotheker
Raphael-Apotheke
25364 Westerhorn
1 Tsai, CH; Chen, ECF; Tsay, HS; Huang, CJ. Wild bitter gourd improves metabolic syndrome:A preliminary dietary supplementation trial.
Nutr J 2012 11:4.Published online 2012,Jan.13 .10.1186/1475-2891-11-4
2 Chen, Q; Chan, LL.; Li, ET: Bitter Melon (Momordica charantia) reduces adiposity , lowers serum insulin and normalizes glucose tolerance in
rats fed a high fat diet. J Nutr. 2003; 133(4):1088-93
3 Matsuda, H.; Li, Y.; Murakami, T.et al Antidiabetic principles of natural medicines III. Structure related inhibitory activity and action mode of
oleanic acid glycosides on hypoglycemic activity. Chem Pharm Bull (Tokyo) 1998;46:399-403
4 Rathi,SS.; Grover, JK.; Vats, V. The effect of Momordica charantia and mucuna pruriens in experimental diabetis and their effect on key
metabolic enzymes involved in carbohydrate metabolism. Phytother Res. 2002; 16(3):236-43
5 Ahmed, I; Adeghate, E; Sharma, AK; Pallot, DJ; Singh,J. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of
stretozotocin- diabetic rat. Diabetes Research and Clinical Practise 1998;40:145-51
6 Day,C.; Cartwright, T.; Provost, J.; Bailey,CJ. Hypoglycaemic effect of Momordica charantia extracts. Planta Med 1990;56: 426-9
7 Miura, T.; Itoh, C.; Iwamoto, N.; Kato,M.; Kawai, M. Hypoglycemic Activity of the fruit of the Momordica charantia in Type 2 diabetic mice.
J Nutr Sci Vitaminol 2001;47:340-44
8 Grover,JK.;Yadaf, SP. Pharmacological actions and potential uses of Momordica charantia: a review J Ethnopharmacol 2004 Jul; 93(1):123-32
9 Chaturved,i P. Antidiabetic potentials of Momordica charantia :multiple mechanisms behind the effects. J Med Food 2012 Feb;15(2):101-7.
Epub 2011
10 Neuwinger, HD. Afrikanische Arzneipflanzen und Jagdgifte Wissenschaftliche Verlagsgesellschaft mbH Stuttgart 2.Auflage 1998 S.404-6
11 R ivera, G. Preliminary chemical and pharmacological studies on cundeamor,Momordica charantia L. Americ.J. Pharm. 1942; 114:72-87
12 Khanna, P; Pangaria, SC; Dixit,VP. Hypoglycaemic activity of polypeptide P from plant sourc J.Nat. Prod. 1981;44: 648-55
13 Sreejayan, M.N.A.,Rao. Oxygen free radical scavenging activity of the juice of Momordica charantia fruits Fitotherapia 1991,344-6
14 Chen, Q; Chan,LL; Li ET; Bitter melon ( Momordica charantia) reduces adiposity,lowers serum insulin and normalizes glucose tolerance in
rats fed a high fat diet. J Nutr 2003;133(4):1088-93
15 Blum, A; Loerz, C; Martin, HJ; Staab-Weijnitz, CA; Maser; E. Momordica charantia extract , a herbal remedy for type 2 diabetes, contains a
specific 11ß-hydroxysteroid dehydrogenase type 1 inhibitor. J of Steroid Biochemistry and Molecular Biology.2012; 128:51-55.
16 Rivera, G. Preliminary chemical and pharmacological studies on cundeamor,Momordica charantia L. Americ.J. Pharm. 1942; 114:72-87
17 Khanna, P.; Pangaria, S.C.; Dixit,V.P. Hypoglycaemic activity of polypeptide P from plant source J.Nat. Prod. 1981;44: 648-55
18 Chen, Q.;Chan LL.; Li ET: Bitter Melon (Momordica charantia) reduces adiposity , lowers serum insulin and normalizes glucose tolerance in
rats fed a high fat diet J Nutr. 2003; 133(4):1088-93
19 Senanayake, GV.; Maruyama,M.; Shibuya,K.; Sakano,M.;Morishita,T.; Yukizaki,C.; Kawano,M; Ohta,H. The effects of bitter melon (Momordica
charantia) on serum and liver triglyceride levels in rats. J Ethnopharmacol 2004 Apr; 91(2-3):257-62 20 Tsai, CH; Chen, ECF; Tsay, HS; Huang,
CJ. Wild bitter gourd improves metabolic syndrome:A preliminary dietary supplementation trial. Nutr J 2012 11:4.Published online 2012,
Jan.13 .10.1186/1475-2891-11-4
21 Zänker, KS; Mang, B; Wolters, M; Hahn, A. Personalized Diabetes and Cancer Medicine :A Rationale for anti-diabetic Nutrition (Bitter Lemon)
in a supportive setting. Current Cancer Therapy Reviews. 2012; 8:66-77
22 Wang, Z; Wang, RM.; Owji, AA. Glucagon-like peptide-1 is a physiological incretin in rat. J Clin Invest 1995;95:417-21 Iovino, A; Scheen,
A. Modulation of tissue exposure to cortisol. A new perspective for reducing the metabolic risk associated with obesity. Rev Med Liege 2010;
65(3):140-6
23 Wang, M. Inhibitors of 11ß-hydroxysteroiddehydrogenase type1 in antidiabetic therapy. Handb Exp Pharmacol 2011;203:127-46
24 Dhanesha N; Joharapurkar, A; Shah, G; et al. Inhibition of 11ß-Hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis
and obesity in db/db mice. Clin Exp. Pharmacol Physiol 2012,39(1):69-77.
25 Boyle, CD; Kowalski, TJ. 11ß-hydroxysteroiddehydrogenase type1 inhibitors: a review of recent patents
Expert Opin Ther Pat 2009 ;19(6):801-25
26 Singh, S; Tice, C. Structure based design of 11ß HSD1 inhibitors. Curr Pharm Biotechnol.2010 Nov.;11(7):779-91
27 Jamieson; PM; Walker, BR; Chapmen; KE; Andrew, R; Rossiter, S; Seckl, JR. 11-ß-Hydroxysteroiddehydrogenase type 1 is a predominant 11-ß-
Reduktase in the intact perfused rat liver. J Endocrinol 2000; 3: 685-693.
28 Chen, Q; Chan,LL; Li ET; Bitter melon ( Momordica charantia) reduces adiposity,lowers serum insulin and normalizes glucose tolerance in
rats fed a high fat diet. J Nutr 2003;133(4):1088-93
29 Leatherdale, BA.; Panesar, RK.; Singh,G; Improvement in glucose tolerance due to Momordica charantia (karela) Br Med J.1981;282:1823-4
30 Zänker, K.; Gottschalk, G.; Hans, S. Sicherheits- und Wirksamkeitsstudie mit einem Extrakt aus Momordica charantia bei Patienten mit Typ-
2-Diabetes Zeitschrift für Phytotherapie 2003; 24:163-9
31 Prinz, S.; Kopp, B. Momordica charantia Österreichische Apothekerzeitung 2004, 3:1-10
32 Chan, W.; Tam, PP.; Yeung, HW. Contraception 1984, 29(1):91-100
33 Nerurkar, P; Ray,RB. Bitter Melon :antagonist to cancer. Pharm Res 2010; 27(6):1049-53
34 Agarwal, RC; Beohar Tripti. Chemopreventive and anticarcinogetic effects of Momordica charantia extract. Asian Pacific Journal of cancer
Prevention.;2010; 11: 371-75
35 Tan MJ et al. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway.
Chem Biol 2008,15(3):263-73